Attached files

file filename
EX-32.1 - EX-32.1 - LogicBio Therapeutics, Inc.logc-ex321_9.htm
EX-31.2 - EX-31.2 - LogicBio Therapeutics, Inc.logc-ex312_1069.htm
EX-31.1 - EX-31.1 - LogicBio Therapeutics, Inc.logc-ex311_1068.htm
EX-23.1 - EX-23.1 - LogicBio Therapeutics, Inc.logc-ex231_406.htm
EX-10.22 - EX-10.22 - LogicBio Therapeutics, Inc.logc-ex1022_360.htm
EX-10.20 - EX-10.20 - LogicBio Therapeutics, Inc.logc-ex1020_407.htm
EX-10.6 - EX-10.6 - LogicBio Therapeutics, Inc.logc-ex106_402.htm
EX-10.4 - EX-10.4 - LogicBio Therapeutics, Inc.logc-ex104_401.htm
EX-10.2 - EX-10.2 - LogicBio Therapeutics, Inc.logc-ex102_404.htm
EX-4.4 - EX-4.4 - LogicBio Therapeutics, Inc.logc-ex44_403.htm
10-K - 10-K - LogicBio Therapeutics, Inc.logc-10k_20191231.htm

Exhibit 21.1

Subsidiaries of the Registrant

 

Name

 

Ownership

Percentage

 

Jurisdiction of

Organization

LOGICBIO AUSTRALIA PTY LIMITED

 

100%

 

Australia

LOGICBIO SECURITIES CORPORATION

 

100%

 

Delaware